Noam Solomon

4 statements across 1 episodes · 1 bullish · 0 bearish · 1 people on the record · first statement Dec 22, 2022 by Noam Solomon · across every show →

On the record as a speaker too: Noam Solomon's record, appearances and statements → this page counts the times other people say the name.

Everything said about Noam Solomon, oldest first

Dec 22, 2022 neutral
Assertion Supported
Solomon: Immunotherapy development costs $2.6B+ with a 90%+ failure rate
“So to develop a new immunotherapy takes more than 2.6 billion dollars. It takes more than 10 years of research and development before market. And more than 90% of drugs fail To get an FDA approval.”
Noam Solomon Dec 22, 2022 ▶ 10:09 HIBT Lab! Immunai: Noam Solomon
Dec 22, 2022 neutral
Opinion
Solomon: Bridging animal testing to humans is biotech's biggest challenge
“Understanding how to bridge the gap between the human immune response and the way that drugs are being tested in animal models. Is, I believe, the biggest challenge that the biopharma and biotechnology industry should face and will face in the coming, ah, deca…”
Noam Solomon Dec 22, 2022 ▶ 11:07 HIBT Lab! Immunai: Noam Solomon
Dec 22, 2022 neutral
Assertion Not checkable as stated
Solomon founded Immunai knowing nothing about biology, medicine, or business
“I started the company. I didn't know anything about biology, medicine, business development, and I had to ask a lot of questions”
Noam Solomon Dec 22, 2022 ▶ 26:17 HIBT Lab! Immunai: Noam Solomon
Dec 22, 2022 positive
Insight
Solomon: Humans lack the intuition to analyze high-dimensional biological data
“No human being will have the intuition to analyze all the relevant data. You have to use a machine to analyze the data.”
Noam Solomon Dec 22, 2022 ▶ 28:40 HIBT Lab! Immunai: Noam Solomon
Made with StarZero

Turn any episode into a week of clips.

This entire site, over 800 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.